WallStreetZenWallStreetZen

NASDAQ: ACRV
Acrivon Therapeutics Inc Stock Ownership - Who owns Acrivon Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Acrivon Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mary MillerCLO2026-10-05294$1.99
$585.06Sell
Peter BlumejensenCEO;Pres2026-08-2514,036$2.21
$30.96kSell
Peter BlumejensenCEO;Pres2026-08-181,229$2.01
$2.47kSell
Mary MillerCLO2026-08-18185$2.01
$371.85Sell
Erick GamelinCXO2026-08-18400$2.01
$804.00Sell
Peter BlumejensenCEO;Pres2026-08-18484$2.01
$972.84Sell
Eric DevroeCOO2026-08-18604$2.01
$1.21kSell
Katharine PetersonCAO2026-08-18101$2.01
$203.01Sell
Adam D. LevyCFO2026-08-041,142$1.57
$1.79kSell
Mary MillerCLO2026-07-21573$1.76
$1.01kSell

1 of 4

ACRV insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ACRV insiders and whales buy or sell their stock.

ACRV Shareholders

What type of owners hold Acrivon Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Chione Ltd8.98%3,848,632$7.35MInsider
Kristina Masson8.61%3,691,232$7.05MInsider
Peter Blumejensen7.69%3,296,252$6.30MInsider
Perceptive Advisors LLC7.24%3,104,139$5.93MInsider
Wellington Biomedical Innovation Master Investors Cayman I LP2.07%888,130$1.70MInsider
Ra Capital Management LP0.99%426,302$814.24kInsider
Eric Devroe0.34%146,349$279.53kInsider
Mary Miller0.19%81,715$156.08kInsider
Adam D. Levy0.15%66,008$126.08kInsider
Erick Gamelin0.12%52,592$100.45kInsider

1 of 3

ACRV vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ACRV0.05%36.80%Net BuyingNet Selling
PMVP0.06%48.83%Net Selling
NTRB0.00%49.04%
CGTX0.02%28.70%Net Selling
CRDF0.02%23.54%Net BuyingNet Buying
View Top Biotech Stocks

Acrivon Therapeutics Stock Ownership FAQ

Who owns Acrivon Therapeutics?

Acrivon Therapeutics (NASDAQ: ACRV) is owned by 0.05% institutional shareholders, 36.80% Acrivon Therapeutics insiders, and 63.15% retail investors. Chione Ltd is the largest individual Acrivon Therapeutics shareholder, owning 3.85M shares representing 8.98% of the company. Chione Ltd's Acrivon Therapeutics shares are currently valued at $7.35M.

If you're new to stock investing, here's how to buy Acrivon Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.